A. V. Samet et al. / Tetrahedron: Asymmetry 19 (2008) 691–694
693
4. Experimental
H-3); 2.26 (dd, J = 9.4, 4.5 Hz, 1H, H-1); 3.22 (t,
J = 5.2 Hz, 1H, H-2); 3.93 (m, 1H, H-10); 4.14 (m, 2H,
CH2); 5.27 (br s, 1H, OH); 7.29 (dd, J = 4.9, 3.8 Hz, 1H);
8.08 (dd, J = 4.9, 1.6 Hz, 1H); 8.19 (m, 1H, HCOO);
12.63 (br s, 1H, COOH). Anal. Calcd for C12H12O6S: C,
50.70; H, 4.25; S, 11.28. Found: C, 50.61; H, 4.40; S, 10.93.
4.1. General
NMR spectra were recorded on a Bruker-DRX500 spec-
1
1
trometer (500.13 MHz for H NMR and 2D H NOESY,
125.75 MHz for 13C). Optical rotations were measured on
a Jasco-340 polarimeter. Compounds 4 were prepared by
a known procedure.24 Levoglucosenone 1 was supplied
4.2.2. Preparation of 6a–d (general procedure). To a solu-
tion of 5a–d (2 mmol) in MeOH (3 ml), concd HCl (0.1 ml)
was added and the mixture was refluxed for 3 h. Then, the
solvent was distilled off at atmospheric pressure, the residue
was kept for 30 min at 80 °C and recrystallized from a suit-
able solvent.
4.2. Synthetic procedures
4.2.1. Preparation of 5a–d (general procedure). To a solu-
tion of 30% aq H2O2 (0.27 g, 2.4 mmol) in glacial AcOH
(2 ml), 4a–d (2 mmol) was added in portions with stirring.
The resulting suspension was gently heated at 30–40 °C
until a clear solution was formed and left for 5 h at rt.
The resulting precipitate of 5a–d was filtered off, washed
thoroughly with water, and dried.
4.2.3. Preparation of 6e–g (‘one-pot’, general proce-
dure). To a solution of 30% aq H2O2 (0.27 g, 2.4 mmol)
in glacial AcOH (2 ml), 4e–g (2 mmol) was added in por-
tions with stirring. The resulting suspension was gently
heated at 30–40 °C, until a clear solution was formed (ca.
20 min) and then left for 5 h at rt. The solvent was removed
in vacuo, and the residue was dissolved in MeOH (3 ml)
with the resulting solution treated as specified above for
the preparation of 6a–d.
4.2.1.1.
(1S,2S,3S)-2-Benzoyl-3-((S)-2-formyloxy-1-
hydroxyethyl)cyclopropanecarboxylic acid 5a. Mp 186–
20
189 °C (EtOH) (decomp.). ½aꢀD ¼ þ112:4 (c 1.0, DMSO).
1H NMR (DMSO-d6): 1.95 (td, J = 9.5, 5.7 Hz, 1H,
H-3); 2.27 (dd, J = 9.3, 4.6 Hz, 1H, H-1); 3.29 (t,
J = 5.2 Hz, 1H, H-2); 3.95 (m, 1H, H-10); 4.16 (m, 2H,
CH2); 5.25 (br s, 1H, OH); 7.57 (t, J = 8.4 Hz, 2H); 7.68
(t, J = 8.4 Hz, 1H); 8.03 (d, J = 8.3 Hz, 2H); 8.20 (s, 1H,
HCOO); 12.61 (br s, 1H, COOH). Anal. Calcd for
C14H14O6: C, 60.43; H, 5.07. Found: C, 60.05; H, 5.32.
4.2.3.1.
(1S,4S,5S,6S)-6-Benzoyl-4-hydroxymethyl-3-
6a. Mp 127–128 °C
oxabicyclo[3.1.0]hexane-2-one
20
(MeOH). ½aꢀD ¼ þ112:8 (c 1.0, DMSO). 1H NMR
(DMSO-d6): 2.64 (dd, J = 6.1, 2.4 Hz, 1H, H-1); 2.70 (dd,
J = 6.1, 3.3 Hz, 1H, H-5); 3.41 (t, J = 3.0 Hz, 1H, H-6);
3.62 (m, 2H, CH2); 4.64 (t, J = 3.6 Hz, 1H, H-4); 5.14 (t,
J = 5.7 Hz, 1H, OH); 7.57 (t, J = 7.6 Hz, 2H); 7.71 (t,
J = 7.3 Hz, 1H); 8.13 (d, J = 7.9 Hz, 2H). 13C NMR
(DMSO-d6): 26.83, 27.33, 29.96, 62.44, 81.03, 128.52,
128.91, 133.92, 136.18, 173.65, 194.99. Anal. Calcd for
C13H12O4: C, 67.23; H, 5.21. Found: C, 67.00; H, 5.33.
4.2.1.2. (1S,2S,3S)-2-(4-Chlorobenzoyl)-3-((S)-2-formyl-
oxy-1-hydroxyethyl)cyclopropanecarboxylic acid 5b. Mp
20
188–190 °C (EtOH) (decomp.). ½aꢀD ¼ þ98:0 (c 1.0,
1
DMSO). H NMR (DMSO-d6): 1.94 (m, 1H, H-3); 2.29
(dd, J = 9.3, 4.6 Hz, 1H, H-1); 3.30 (t, J = 5.3 Hz, 1H,
H-2); 3.93 (m, 1H, H-10); 4.12 (dd, J = 11.0, 4.3 Hz, 1H,
CH2); 4.18 (dd, J = 11.0, 5.8 Hz, 1H, CH2); 5.24 (br s,
1H, OH); 7.64 (d, J = 8.5 Hz, 2H); 8.07 (d, J = 8.5 Hz,
2H); 8.20 (s, 1H, HCOO); 12.63 (br s, 1H, COOH). 13C
NMR (DMSO-d6): 27.90, 28.98, 33.77, 64.91, 67.28,
129.07, 130.12, 135.08, 138.65, 162.17, 170.81, 195.09.
Anal. Calcd for C14H13ClO6: C, 53.77; H, 4.19; Cl, 11.34.
Found: C, 54.08; H, 3.96; Cl, 11.10.
4.2.3.2. (1S,4S,5S,6S)-6-(4-Chlorobenzoyl)-4-hydroxy-
methyl-3-oxabicyclo[3.1.0]hexane-2-one 6b. Mp 184–
20
1
185 °C (EtOH). ½aꢀD ¼ þ88:1 (c 1.0, DMSO). H NMR
(DMSO-d6): 2.65 (dd, J = 6.1, 2.5 Hz, 1H, H-1); 2.71 (dd,
J = 6.1, 3.2 Hz, 1H, H-5); 3.42 (t, J = 3.0 Hz, 1H, H-6);
3.62 (m, 2H); 4.63 (t, J = 3.6 Hz, 1H, H-4); 5.12 (br s,
1H, OH); 7.64 (d, J = 8.5 Hz, 2H); 8.16 (d, J = 8.5 Hz,
2H). Anal. Calcd for C13H11ClO4: C, 58.55; H, 4.16; Cl,
13.29. Found: C, 58.81; H, 3.99; Cl, 13.42.
4.2.1.3. (1S,2S,3S)-2-(4-Bromobenzoyl)-3-((S)-2-formyl-
oxy-1-hydroxyethyl)cyclopropanecarboxylic acid 5c. Mp
4.2.3.3. (1S,4S,5S,6S)-6-(4-Bromobenzoyl)-4-hydroxy-
methyl-3-oxabicyclo[3.1.0]hexane-2-one 6c. Mp 195–
20
20
1
190–193 °C (EtOH) (decomp.). ½aꢀD ¼ þ89:6 (c 0.5, DMSO).
197 °C (EtOH). ½aꢀD ¼ þ79:7 (c 1.0, DMSO). H NMR
(DMSO-d6): 2.63 (dd, J = 6.1, 2.5 Hz, 1H, H-1); 2.69 (dd,
J = 6.2, 3.4 Hz, 1H, H-5); 3.41 (t, J = 3.0 Hz, 1H, H-6);
3.61 (m, 2H); 4.62 (t, J = 3.6 Hz, 1H, H-4); 5.13 (br s,
1H, OH); 7.78 (d, J = 8.5 Hz, 2H); 8.07 (d, J = 8.5 Hz,
2H). Anal. Calcd for C13H11BrO4: C, 50.18; H, 3.56; Br,
25.68. Found: C, 49.89; H, 3.60; Br, 26.00.
1H NMR (DMSO-d6): 1.94 (td, J = 9.5, 5.8 Hz, 1H, H-3);
2.29 (dd, J = 9.5, 4.6 Hz, 1H, H-1); 3.30 (t, J = 5.2 Hz, 1H,
H-2); 3.93 (m, 1H, H-10); 4.12 (dd, J = 11.1, 4.6 Hz, 1H,
CH2); 4.18 (dd, J = 11.1, 5.7 Hz, 1H, CH2); 5.25 (br s, 1H,
OH); 7.79 (d, J = 8.5 Hz, 2H); 7.97 (d, J = 8.5 Hz, 2H);
8.20 (s, 1H, HCOO); 12.63 (br s, 1H, COOH). Anal. Calcd
for C14H13BrO6: C, 47.08; H, 3.67; Br, 22.37. Found: C,
46.78; H, 3.60; Br, 22.60.
4.2.3.4. (1S,4S,5S,6S)-4-Hydroxymethyl-6-(2-thienoyl)-
3-oxabicyclo[3.1.0]hexane-2-one
6d. Mp
202–203 °C
20
4.2.1.4. (1S,2S,3S)-2-((S)-2-Formyloxy-1-hydroxyethyl)-
3-(2-thienoyl)cyclopropanecarboxylic acid 5d. Mp 192–
(MeOH). ½aꢀD ¼ þ112:4 (c 1.0, DMSO). 1H NMR
(DMSO-d6): 2.75 (dd, J = 6.2, 2.6 Hz, 1H, H-1); 2.89 (dd,
J = 6.2, 3.3 Hz, 1H, H-5); 3.42 (t, J = 3.0 Hz, 1H, H-6);
3.63 (m, 2H); 4.60 (t, J = 3.6 Hz, 1H, H-4); 5.16 (t,
20
195 °C (EtOH) (decomp.). ½aꢀD ¼ þ140:0 (c 0.8, DMSO).
1H NMR (DMSO-d6): 1.91 (td, J = 9.5, 5.8 Hz, 1H,